Nurix Therapeutics, Inc.

Healthcare

NASDAQ:NRIX · NASDAQ Global Market

Market Cap $1.52B Beta 1.87 P/E (TTM) -6.4

$17.55 +0.85%

+$0.15 today

52W Low $8.20High $22.50

Vol 3.23M · Avg 1.74M

EPS (TTM) -$2.68Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+46.49%

Period High

$21.47

Period Low

$8.24

Latest

$17.55

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tango Therapeutics, Inc.

NASDAQ:TNGX

$3.54B

Kodiak Sciences Inc.

NASDAQ:KOD

$1.88B

UroGen Pharma Ltd.

NASDAQ:URGN

$1.58B

Septerna, Inc.

NASDAQ:SEPN

$1.58B

Fortrea Holdings Inc.

NASDAQ:FTRE

$1.44B

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$1.13B

Xencor, Inc.

NASDAQ:XNCR

$932.46M

Kura Oncology, Inc.

NASDAQ:KURA

$853.03M

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

$852.31M

BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

$610.42M

What is the latest NRIX filing?

The latest filing shown is 8-K dated Jun 11, 2026.

How many recent filings does NRIX have?

Intrinsic Alpha currently shows 20 recent filings for NRIX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.